This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Cytune Pharma. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mont-Saint-Guibert, BE (2020)
- Mont-St-Guibert, BE (2024)
Company Filing History:
Years Active: 2020-2024
Title: Guy De Martynoff: Innovator in Biopharmaceuticals
Introduction
Guy De Martynoff is a notable inventor based in Mont-Saint-Guibert, Belgium. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of purification methods for therapeutic proteins. With a total of 2 patents to his name, his work continues to impact the industry.
Latest Patents
One of his latest patents is focused on the IL-15/IL-15Ralpha based conjugates purification method. This invention relates to a method for preparing a composition that includes monomeric conjugates from a sample. The conjugate comprises a polypeptide with the amino acid sequence of interleukin 15 or its derivatives, along with a polypeptide that includes the amino acid sequence of the sushi domain of IL-15Rα or its derivatives. The method employs anion-exchange chromatography followed by hydrophobic interaction chromatography, leading to a pharmaceutical composition that can be obtained through this process.
Career Highlights
Guy De Martynoff is currently associated with Cytune Pharma, where he continues to innovate in the biopharmaceutical sector. His expertise in protein purification methods has positioned him as a key player in the development of new therapeutic solutions.
Collaborations
He collaborates with David Bechard, contributing to advancements in their field through shared knowledge and expertise.
Conclusion
Guy De Martynoff's contributions to biopharmaceuticals, particularly through his innovative purification methods, highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in therapeutic protein development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile